Literature DB >> 29132528

An Update on Inflammatory Bowel Disease.

Tomoko Sairenji1, Kimberly L Collins2, David V Evans3.   

Abstract

Inflammatory bowel disease (IBD) includes 2 chronic idiopathic inflammatory diseases: ulcerative colitis and Crohn disease. The incidence and prevalence of IBD is increasing worldwide. It can affect people of all ages, including children and geriatric populations, and can impact all aspects of life. In this article, diagnosis and treatment of IBD in adults, pediatric, pregnant, and elderly populations are explored from the perspective of a primary care physician.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crohn disease; Diagnosis; Elderly patients; Inflammatory bowel disease; Pediatric patients; Special populations; Treatment; Ulcerative colitis

Mesh:

Substances:

Year:  2017        PMID: 29132528     DOI: 10.1016/j.pop.2017.07.010

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  91 in total

1.  Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation.

Authors:  Yang Chen; Yan Jin; Catherine Stanton; R Paul Ross; Jianxin Zhao; Hao Zhang; Bo Yang; Wei Chen
Journal:  Eur J Nutr       Date:  2020-04-29       Impact factor: 5.614

2.  A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease.

Authors:  Robert Battat; Jonathan S Galati; Dana Lukin; Fatiha Chabouni; Robbyn Sockolow; Jeff Carter; Kristina Fajardo; Stevie Yang; Jenna Reich; Vinita Jacobs; Meira Abramowitz; Anand Kumar; Paul Christos; Randy S Longman; Robert Burakoff; Laura Simone; Tamar Sapir; Carl V Crawford; Ellen J Scherl
Journal:  J Clin Gastroenterol       Date:  2022-03-01       Impact factor: 3.062

3.  Self-reported Treatment Goals in Chinese Patients with Inflammatory Bowel Disease During the Coronavirus Disease 2019 Pandemic.

Authors:  Wen-Ning Tian; Yu-Hong Huang; Min Jiang; Cong Dai
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

4.  Alpha-Linolenic Acid Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.

Authors:  Jeongtae Kim; Meejung Ahn; Yuna Choi; Taeyoung Kang; Jungeun Kim; Nam Ho Lee; Gi Ok Kim; Taekyun Shin
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

5.  Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites.

Authors:  Junfeng Zou; Yumeng Shen; Mengjun Chen; Zhimiao Zhang; Suwei Xiao; Chen Liu; Yue Wan; Lei Yang; Shu Jiang; Erxin Shang; Dawei Qian; Jinao Duan
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-17       Impact factor: 4.813

6.  Optical coherent tomography to evaluate the degree of inflammation in a mouse model of colitis.

Authors:  Jian Ding; Jiewen Lin; Qiu Li; Xiaoping Chen; Weiqiang Chen; Qiukun Zhang; Shanshan He; Ting Wu; Chengdang Wang; Shuncong Zhong; Dan Li
Journal:  Quant Imaging Med Surg       Date:  2020-05

Review 7.  Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.

Authors:  Yao Chen; Xiang Wang
Journal:  Brain Behav       Date:  2021-05-07       Impact factor: 2.708

8.  Protective Effect of Asacol in Combination with Pantoprazole in Ulcerative Colitis Patients Who Defecate Asacol Tablets Intactly: A Clinical Trial Study.

Authors:  Homayoon Bashiri; Arezoo Bozorgomid
Journal:  Clin Exp Gastroenterol       Date:  2020-01-24

9.  Protection by microRNA-7a-5p Antagomir Against Intestinal Mucosal Injury Related to the JNK Pathway in TNBS-Induced Experimental Colitis.

Authors:  Bao Yin; Huang Tian-Chu; Xu Ling-Fen
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.852

10.  Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study.

Authors:  Tzu-Chen Lo; Yu-Yen Chen; Hsin-Hua Chen
Journal:  Eye (Lond)       Date:  2021-06-21       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.